Category: pharma & healthcare

Cold-Causing Coronaviruses Can Kill

Many hope Covid-19 will soon become one of many seasonal cold-causing coronaviruses. They don’t know that these viruses can often still be lethal.

New Study May Explain Why Hair Goes Gray

A recent study published in Nature may have uncovered why hair color fades with age, and most importantly, how we may be able to reverse it.

A New Generation Of Flexible And Controllable CAR T Therapies

In this first installment, we discuss an adaptor system which extends the control and potential of CAR T therapy.

Man Destined For Alzheimer’s Pushes Condition Back 20 Years

The gene that allowed a man destined for early-onset Alzheimer’s to postpone dementia until age 72 may be key in developing new meds to prevent this disease.

How Did Egypt Eliminate Hepatitis C In Less Than One Year?

How Did Egypt Eliminate Hepatitis C In Less Than One Year?

The Many Functions Of The Hepatitis D Antigen Proteins

Hepatitis D virus is responsible for the most severe form of viral hepatitis. It produces two antigen proteins, both of which are critical to the viral life cycle.

UnitedHealthcare Will Soon Implement A Controversial Prior Authorization Policy For Surveillance And Diagnostic Colonoscopies

On June 1st, UnitedHealthcare will implement a controversial prior authorization policy for surveillance and diagnostic colonoscopies.

A New Hope For Osteoarthritis Treatment And Prevention (Part 2)

In this second installment of our stories on osteoarthritis, we discuss a new approach for treatment and cure.

America’s Gun Violence Is A Public Health Emergency, But Politics And The Courts Prevent A Proper Response

Gun violence is a leading cause of premature death in the U.S. In 2021, more than 48,000 Americans died from guns. Repeated attempts to introduce gun control measures have run into formidable opposition in the U.S. Congress as well as the judiciary.

PBM Reform Legislation May Be One Step Closer To Reality, But It’s Missing Two Key Components

Given the agreement on PBM reform across a disparate group of stakeholders, perhaps the two missing components in the proposed legislation – pass-through to patients and delinkage of PBM rebates and fees from list prices – will eventually find a way to…